Paper41347780
Genomic diversity and adaptive resistance mechanisms in Pseudomonas aeruginosa from bronchiectasis.
Xiao Y and 10 others. mSystems, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Genomic diversity and adaptive resistance mechanisms in Pseudomonas aeruginosa from bronchiectasis. Papers, record 41347780. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41347780
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Genomic diversity and adaptive resistance mechanisms in Pseudomonas aeruginosa from bronchiectasis.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pseudomonas aeruginosa | Major topic |
| Bronchiectasis | Major topic |
| Pseudomonas Infections | Major topic |
| Genetic Variation | Major topic |
| Drug Resistance, Bacterial | Major topic |
| Humans | |
| Animals | |
| Virulence | |
| Bacterial Proteins | |
| Biofilms | |
| Anti-Bacterial Agents | |
| Phylogeny | |
| Genome, Bacterial | |
| Whole Genome Sequencing | |
| Virulence Factors | |
| Microbial Sensitivity Tests |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 20252BAC200441, YFYPY202413, GJJ2400132 | Natural Science Foundation of Jiangxi Province | PubMed | ||
| 20212BAB216041 | Natural Science Foundation of Jiangxi Province | PubMed | ||
| 82460397, 82260085 | National Natural Science Foundation of China | PubMed |
Source PubMed
References61
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38271608 | Airway "Resistotypes" and Clinical Outcomes in Bronchiectasis. | Am J Respir Crit Care Med | 2024 | https://conductscience.org/library/papers/38271608 | PubMed |
| 2 | 34739369 | Bakta: rapid and standardized annotation of bacterial genomes via alignment-free sequence identification. | Microb Genom | 2021 | https://conductscience.org/library/papers/34739369 | PubMed |
| 3 | 31029489 | Reproducibility of broth microdilution MICs for the novel siderophore cephalosporin, cefiderocol, determined using iron-depleted cation-adjusted Mueller-Hinton broth. | Diagn Microbiol Infect Dis | 2019 | https://conductscience.org/library/papers/31029489 | PubMed |
| 4 | 31724047 | Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin. | Clin Infect Dis | 2019 | https://conductscience.org/library/papers/31724047 | PubMed |
| 5 | 32780112 | ResFinder 4.0 for predictions of phenotypes from genotypes. | J Antimicrob Chemother | 2020 | https://conductscience.org/library/papers/32780112 | PubMed |
| 6 | 32698896 | Producing polished prokaryotic pangenomes with the Panaroo pipeline. | Genome Biol | 2020 | https://conductscience.org/library/papers/32698896 | PubMed |
| 7 | 25200914 | Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance. | Respir Med | 2015 | https://conductscience.org/library/papers/25200914 | PubMed |
| 8 | 26040456 | Assembling short reads from jumping libraries with large insert sizes. | Bioinformatics | 2015 | https://conductscience.org/library/papers/26040456 | PubMed |
| 9 | 28634241 | Psl Produced by Mucoid Pseudomonas aeruginosa Contributes to the Establishment of Biofilms and Immune Evasion. | mBio | 2017 | https://conductscience.org/library/papers/28634241 | PubMed |
| 10 | 37627724 | The Art of War with Pseudomonas aeruginosa: Targeting Mex Efflux Pumps Directly to Strategically Enhance Antipseudomonal Drug Efficacy. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37627724 | PubMed |
| 11 | 35930458 | Airway acidification impaired host defense against Pseudomonas aeruginosa infection by promoting type 1 interferon β response. | Emerg Microbes Infect | 2022 | https://conductscience.org/library/papers/35930458 | PubMed |
| 12 | 35740130 | Cefiderocol: Systematic Review of Mechanisms of Resistance, Heteroresistance and In Vivo Emergence of Resistance. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/35740130 | PubMed |
| 13 | 30405616 | Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host? | Front Immunol | 2018 | https://conductscience.org/library/papers/30405616 | PubMed |
| 14 | 26705697 | Trade-off Mechanisms Shaping the Diversity of Bacteria. | Trends Microbiol | 2016 | https://conductscience.org/library/papers/26705697 | PubMed |
| 15 | 40240992 | Loss of OprD function is sufficient for carbapenem-resistance-only but insufficient for multidrug resistance in Pseudomonas aeruginosa. | BMC Microbiol | 2025 | https://conductscience.org/library/papers/40240992 | PubMed |
| 16 | 30240613 | CRISPR/Cas9-based Genome Editing in Pseudomonas aeruginosa and Cytidine Deaminase-Mediated Base Editing in Pseudomonas Species. | iScience | 2018 | https://conductscience.org/library/papers/30240613 | PubMed |
| 17 | 11577145 | Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. | Microbiology (Reading) | 2001 | https://conductscience.org/library/papers/11577145 | PubMed |
| 18 | 30692969 | Persistence and Microevolution of Pseudomonas aeruginosa in the Cystic Fibrosis Lung: A Single-Patient Longitudinal Genomic Study. | Front Microbiol | 2018 | https://conductscience.org/library/papers/30692969 | PubMed |
| 19 | 9423869 | Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge. | Infect Immun | 1998 | https://conductscience.org/library/papers/9423869 | PubMed |
| 20 | 31803263 | Hot topics and current controversies in non-cystic fibrosis bronchiectasis. | Breathe (Sheff) | 2019 | https://conductscience.org/library/papers/31803263 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42856588 | Treatable traits-based management of bronchiectasis: moving from theory to clinical practice. | Chin Med J Pulm Crit Care Med | 2026 | https://conductscience.org/library/papers/42856588 | PubMed |
| 41772443 | Molecular characteristics of chromosome-mediated colistin resistance in carbapenem-resistant Pseudomonas aeruginosa isolates from a tertiary hospital in China. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/41772443 | PubMed |
| 41700875 | Comparison of clinical and microbiological features between mucoid and non-mucoid Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis. | Microbiol Spectr | 2026 | https://conductscience.org/library/papers/41700875 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41347780
GET https://conductscience.org/api/papers/v1/41347780/references?page=2